Lannett Triamterene and Hydrochlorothiazide Capsules Recall

Why it was recalled

Failed Impurity/Degradation Specifications

Product description

Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, 1000 Capsules per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC: 0527-1632-10

Lot numbers, UPCs & expiration codes

Lots: 20256318A (12/2022), 20256321A (12/2022), 21000238A (01/2023)

Where it was sold

Nationwide USA

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-0160-2023
Classification: Class III
Status: Terminated
Recall initiated: Nov 9, 2022
FDA report date: Jan 25, 2023
Quantity: 5,640 bottles
Recall type: Voluntary: Firm initiated
Recalling firm: Lannett Company Inc.

Original FDA data

Every field from FDA enforcement report D-0160-2023, exactly as published.

Show all FDA fields

City: Seymour
State: IN
Status: Terminated
Country: United States
Event ID: 91142
Address: 1101 C Ave W
Code information: Lots: 20256318A (12/2022), 20256321A (12/2022), 21000238A (01/2023)
Postal code: 47274-3342
Report date: Jan 25, 2023
Product type: Drugs
Recall number: D-0160-2023
Classification: Class III
Recalling firm: Lannett Company Inc.
Product quantity: 5,640 bottles
Termination date: Jun 8, 2023
Reason for recall: Failed Impurity/Degradation Specifications
Voluntary / mandated: Voluntary: Firm initiated
Product description: Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, 1000 Capsules per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC: 0527-1632-10
Distribution pattern: Nationwide USA
Recall initiation date: Nov 9, 2022
Initial firm notification: Letter
Center classification date: Jan 16, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0160-2023, published Jan 25, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.